At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 50 enrolled
Drug / intervention
Normal saline (1000 mL) +1 moreother
Likely dose
Normal saline (1000 mL)from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache: a Pilot Randomized Controlled Trial
In Brief
A Phase 3 clinical trial evaluating Normal saline (1000 mL) and Control for Migraine Headache. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether patients in the emergency department with migraine headache who are administered an intravenous fluid bolus will report greater improvement in pain scores than control patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine Headache
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2017201820192020202120222023202420252026
First PostedOct 2016
Enrollment StartJan 2017
Primary CompletionSep 2017
Study CompletionSep 2017
TodayJul 2026
First PostedOct 14, 2016
Enrollment StartJan 1, 2017
Primary CompletionSep 26, 2017
Study CompletionSep 28, 2017
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 9.7 years ago
Interventions
Normal saline (1000 mL)other
Controlother